Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors

2006 ◽  
Vol 21 (12) ◽  
pp. 2090-2095 ◽  
Author(s):  
Michael P. Hill ◽  
Paula Ravenscroft ◽  
Steven G. McGuire ◽  
Jonathan M. Brotchie ◽  
Alan R. Crossman ◽  
...  
Keyword(s):  
Dopamine Receptors ◽  
Dopamine Receptor ◽  
Receptor Agonist ◽  
Dopamine Receptor Agonist ◽  
The Novel ◽  
D2 Dopamine Receptor

scholarly journals The D2 dopamine receptor agonist bromocriptine enhances voluntary but not involuntary spatial attention in humans

2010 ◽  
Vol 10 (7) ◽  
pp. 155-155
Author(s):  
W. Prinzmetal ◽  
A. Rokem ◽  
A. Landau ◽  
D. Wallace ◽  
M. Silver ◽  
...  
Keyword(s):  
Dopamine Receptor ◽  
Spatial Attention ◽  
Receptor Agonist ◽  
Dopamine Receptor Agonist ◽  
D2 Dopamine Receptor

scholarly journals Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046

1997 ◽  
Vol 120 (6) ◽  
pp. 1101-1113 ◽  
Author(s):  
Dirk J Duncker ◽  
David B Haitsma ◽  
Ingeborg E J van der Geest ◽  
Rene Stubenitsky ◽  
Jan R Van Meegen ◽  
...  
Keyword(s):  
Dopamine Receptor ◽  
Receptor Agonist ◽  
Treadmill Exercise ◽  
Dopamine Receptor Agonist ◽  
The Novel
Sign in / Sign up

Export Citation Format

Share Document